ArticleMedical oncology (Northwood, London, England)2015

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.

James R Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.